Dakota Wealth Management cut its holdings in The Clorox Company (NYSE:CLX – Free Report) by 13.4% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 11,896 shares of the company’s stock after selling 1,843 shares during the period. Dakota Wealth Management’s holdings in Clorox were worth $1,932,000 as of its most recent filing with the SEC.
Several other institutional investors and hedge funds have also modified their holdings of the business. Eads & Heald Wealth Management grew its stake in shares of Clorox by 2.3% in the fourth quarter. Eads & Heald Wealth Management now owns 8,129 shares of the company’s stock valued at $1,320,000 after acquiring an additional 180 shares in the last quarter. Ballentine Partners LLC grew its stake in shares of Clorox by 5.4% in the fourth quarter. Ballentine Partners LLC now owns 2,608 shares of the company’s stock valued at $424,000 after acquiring an additional 134 shares in the last quarter. Culbertson A N & Co. Inc. grew its stake in shares of Clorox by 52.1% in the fourth quarter. Culbertson A N & Co. Inc. now owns 14,362 shares of the company’s stock valued at $2,333,000 after acquiring an additional 4,919 shares in the last quarter. ZWJ Investment Counsel Inc. grew its stake in shares of Clorox by 6.6% in the fourth quarter. ZWJ Investment Counsel Inc. now owns 1,918 shares of the company’s stock valued at $312,000 after acquiring an additional 118 shares in the last quarter. Finally, Kelly Financial Services LLC acquired a new position in shares of Clorox in the fourth quarter valued at about $325,000. 78.53% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
Several research firms recently weighed in on CLX. Barclays cut their price objective on shares of Clorox from $139.00 to $130.00 and set an “underweight” rating for the company in a research report on Friday, January 17th. Evercore ISI cut their price objective on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating for the company in a research report on Monday, October 14th. StockNews.com cut shares of Clorox from a “buy” rating to a “hold” rating in a research report on Sunday, January 5th. Jefferies Financial Group raised shares of Clorox from a “hold” rating to a “buy” rating and upped their price objective for the stock from $174.00 to $187.00 in a research report on Tuesday, October 1st. Finally, DA Davidson upped their price objective on shares of Clorox from $153.00 to $171.00 and gave the stock a “neutral” rating in a research report on Monday, November 4th. Four equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has assigned a buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $156.54.
Clorox Stock Performance
Clorox stock opened at $160.81 on Friday. The business has a 50 day moving average of $163.93 and a 200-day moving average of $157.11. The Clorox Company has a 1 year low of $127.60 and a 1 year high of $171.37. The company has a debt-to-equity ratio of 11.08, a current ratio of 1.00 and a quick ratio of 0.62. The company has a market capitalization of $19.90 billion, a P/E ratio of 56.03, a P/E/G ratio of 2.95 and a beta of 0.42.
Clorox (NYSE:CLX – Get Free Report) last released its quarterly earnings data on Wednesday, October 30th. The company reported $1.86 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.36 by $0.50. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The company had revenue of $1.76 billion during the quarter, compared to the consensus estimate of $1.64 billion. During the same quarter in the prior year, the firm posted $0.49 earnings per share. The firm’s revenue was up 27.0% compared to the same quarter last year. On average, equities research analysts predict that The Clorox Company will post 6.87 earnings per share for the current year.
Clorox Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Wednesday, January 29th will be paid a $1.22 dividend. This represents a $4.88 annualized dividend and a dividend yield of 3.03%. The ex-dividend date is Wednesday, January 29th. Clorox’s dividend payout ratio is currently 170.04%.
Clorox Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
See Also
- Five stocks we like better than Clorox
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Market Momentum: 3 Stocks Poised for Significant Breakouts
- How to Most Effectively Use the MarketBeat Earnings Screener
- Kinder Morgan’s Uptrend is Only Half Over: New Highs Are Coming
- EV Stocks and How to Profit from Them
- Momentum Builders: 3 Stocks Positioned to Shine This Quarter
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.